Truist Financial analyst David S Macdonald reiterated a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...
After a dismal 2024, CVS Health (NYSE:CVS) could be starting to turn itself around. Some investors seem convinced, especially after the retail drugstore chain on Wednesday posted a big beat on ...
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Encompass Health (EHC – Research Report), with a ...
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...
Elevance Health is the only health insurance company of 10 Moody's Ratings evaluated that received a "positive" credit ...
Cigna has also been on the defensive when it comes to pharmacy costs. The company operates one of the largest pharmacy benefit managers in the country, Express Scripts, which together with CVS ...
Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...
Lawmakers determined to enact new restrictions on pharmacy benefit managers are trying to include legislation, which nearly ...
CVS Health's CVS.N Caremark, Cigna's Express Scripts and UnitedHealth Group's UNH.N Optum together control the majority of the U.S. pharmacy benefit market, while their parent companies ...